SERB

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

Years since formation: 5 years; since Feb 19, 2020
Type: Norwegian division of foreign business enterprise
VAT registered: No
Number of employees: 0

Financials

Annual total result 2023: -2,782,755; NOK
Total equity 2023: -7,055,476; NOK

Last update: Aug 29, 2024

Management

Board

Name	Role	Shares
LB Luc Bodet 1974	Contact Person	-
S SERB	Information about the Company in the Home Country	-

Last update: Apr 13, 2023

Ownership

No available data

Financials

in NOK

Summary

Year	2023	2022
Total operating income	0	0
Annual Total Result	-2,782,755	-2,206,820
Total assets	0	0
Total liabilities	7,055,476	2,206,820
Total equity	-7,055,476	-2,206,820

P&L

Year	2023	2022
Total operating income	0	0
Total operating costs	2,782,755	2,206,820
Operating result	-2,782,755	-2,206,820
Financial income/costs	0	0
Profit before tax	-2,782,755	-2,206,820
Total tax & extraordinary income/cost	0	0
Annual Total Result	-2,782,755	-2,206,820

Balance overview

Year	2023	2022
Total fixed assets	0	0
Total current assets	0	0
Total assets	0	0
Short term debt	7,055,476	2,206,820
Long term debt	0	0
Total liabilities	7,055,476	2,206,820
Contributed capital	0	0
Retained earnings	-7,055,476	-2,206,820
Total equity	-7,055,476	-2,206,820
Total equity and liabilities	0	0

SERB924 580 941

SERB

Keywords

Organization

Financials

Management

Board

Ownership

Financials

Summary

P&L

Balance overview

Classification